Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors
Somatostatin receptor type 2 (SSTR2) is one of the five subtypes of somatostatin receptors and is overexpressed on the surface of most gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs), pituitary tumors, paraganglioma, and meningioma, as well as hepatocellular carcinoma and breast cancer. Ch...
| 發表在: | OncoImmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Taylor & Francis Group
2024-12-01
|
| 主題: | |
| 在線閱讀: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2412371 |
